Anti-diabetic drug metformin inhibits disease progression in Alport syndrome mouse model

Researchers from Kumamoto University (Japan) have found that the anti-diabetic drug metformin significantly prolongs the survival of mice in a model that simulates the pathology of non-diabetic chronic kidney disease (ND-CKD) by ameliorating pathological conditions like reduced kidney function, glomerular damage, inflammation and fibrosis. Metformin's mechanism is different from existing therapeutics which only treat symptoms, such as the blood pressure […]

Read more

Azithromycin Mylan

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. AZITHROMYCIN MYLAN azithromycin (as dihydrate) CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Azithromycin Mylan. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits […]

Read more

Machine learning comes of age in cystic fibrosis

World-leading AI technology developed by the Cambridge Centre for AI in Medicine and their colleagues offers a glimpse of the future of precision medicine, and unprecedented predictive power to clinicians caring for individuals with cystic fibrosis. Accurately predicting how an individual’s chronic illness is going to progress is critical to delivering better-personalized, precision medicine. Only with such insight can a […]

Read more

World-first technology breathes new life into cystic fibrosis detection and treatment

World-first research led by Monash University could hold the key to better monitoring and treatment of lung disease associated with cystic fibrosis (CF) – a condition thousands of people are diagnosed with each year. Using X-ray velocimetry (XV), the multi-disciplinary collaboration of physicists, engineers, biomedical engineers and clinicians was able to measure the dynamics of airflow through the lungs during […]

Read more

Scientists reverse fibrosis in preclinical studies

In cell and mouse models, Mayo Clinic researchers and collaborators have identified a way to slow and reverse the process of uncontrolled internal scarring, called fibrosis. This disease process has few effective therapies, no cure and can be fatal when it occurs in organs such as the liver (cirrhosis) or lungs (pulmonary fibrosis). The findings appear Wednesday, Oct. 30, in […]

Read more

Father with cystic fibrosis gets lung transplant fourth time lucky

Father with cystic fibrosis who recorded poignant messages for his twins to remember him by receives new lung after three false alarms James Beeching, 36, has had the incurable genetic condition since he was two  Three lung transplants fell through, as his condition deteriorated His heartwrenching video on Facebook, talking to his twins, got 16,000 shares He finally got a […]

Read more